Vagus Nerve Stimulation for Autonomic Dysfunction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current pharmacological therapies for hypertension and atrial fibrillation often lead to prolonged hypotension and require long-term anticoagulation or ant-arrhythmic therapies, which are costly and have adverse effects, while existing treatments for sporadic hypertension and atrial fibrillation initiation are inadequate.
Innovation Solution
A system comprising an ear device and wearable device connected to an ANS management device that monitors heart rate variability and automatically initiates transcutaneous stimulation of the vagus nerve to restore autonomic nervous system balance, preventing atrial fibrillation and hypertension without causing hypotension.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If higher doses of antihypertensive medication are administered to treat sporadic hypertension, then blood pressure control is improved, but prolonged hypotension and fall risks increase
Solution Approach 1:
The system uses periodic vagus nerve stimulation delivered in controlled bursts (e.g., 30 seconds on, 30 seconds off) rather than continuous stimulation. This periodic approach allows blood pressure to be regulated during stimulation phases while avoiding sustained hypotension between phases, resolving the contradiction between effective BP control and avoidance of prolonged hypotension
Solution Approach 2:
The system continuously monitors blood pressure and heart rate variability, using this feedback to adjust stimulation intensity and duration in real-time. When blood pressure drops below target ranges, stimulation is reduced or paused, preventing prolonged hypotension while maintaining effective blood pressure control during elevated states
2Reliability
If pharmacological therapy is used to treat atrial fibrillation, then heart rhythm control is achieved, but long-term anticoagulation and anti-arrhythmic therapies with adverse effects are required
Solution Approach 1:
The system detects early signs of atrial fibrillation through heart rate variability monitoring and applies vagus nerve stimulation before full-blown AF episodes develop. By intervening preliminarily during the initiation phase, the system prevents AF establishment without requiring long-term pharmacological suppression, avoiding associated adverse effects
Solution Approach 2:
The system empowers patients to self-manage their condition through portable devices that deliver therapy as needed based on self-monitored physiological parameters. This eliminates the need for continuous medical supervision and long-term medication regimens, reducing adverse effects while maintaining heart rhythm control
3Reliability
If the pill in pocket approach is used for sporadic hypertension, then acute blood pressure increases are treated, but sustained pharmacological effects cause hypotension
Solution Approach 1:
The system delivers stimulation in short, periodic bursts (e.g., 30 seconds) rather than continuously, mirroring the acute-on-demand need for blood pressure management. This provides effective treatment during hypertensive episodes while allowing full recovery between bursts, avoiding the sustained hypotension caused by long-acting pharmacological rescue pills
Data Source
AI summary
Methods and systems for alleviating disorders and complications associated with autonomic nervous system dysfunction. The approach generally includes measuring heart rate signals from a subject to measure heart rate variability and determine a heart rate variability threshold, determining that the subject is experiencing autonomic nervous system dysfunction, and alerting the subject to stimulate the auricular branch of the vagus nerve with an ear device.